Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1997 Sep;61(3):590–598. doi: 10.1086/515517

Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimerase.

B B Quimby 1, A Alano 1, S Almashanu 1, A M DeSandro 1, T M Cowan 1, J L Fridovich-Keil 1
PMCID: PMC1715948  PMID: 9326324

Abstract

UDP-galactose-4-epimerase (GALE) is a highly conserved enzyme that catalyzes the interconversion of UDP-galactose and UDP-glucose. Impairment of this enzyme in humans results in one of two clinically distinct forms of epimerase-deficiency galactosemia-one benign, the other severe. The molecular and biochemical distinction between these disorders remains unknown. To enable structural and functional studies of both wild-type and patient-derived alleles of human GALE (hGALE), we have developed and applied a null-background yeast expression system for the human enzyme. We have demonstrated that wild-type hGALE sequences phenotypically complement a yeast gal10 deletion, and we have biochemically characterized the wild-type human enzyme isolated from these cells. Furthermore, we have expressed and characterized two mutant alleles, L183P-hGALE and N34S-hGALE, both derived from a patient with no detectable GALE activity in red blood cells but with approximately 14% activity in cultured lymphoblasts. Analyses of crude extracts of yeast expressing L183P-hGALE demonstrated 4% wild-type activity and 6% wild-type abundance. Extracts of yeast expressing N34S-hGALE demonstrated approximately 70% wild-type activity and normal abundance. However, yeast coexpressing both L183P-hGALE and N34S-hGALE exhibited only approximately 7% wild-type levels of activity, thereby confirming the functional impact of both substitutions and raising the intriguing possibility that some form of dominant-negative interaction may exist between the mutant alleles found in this patient. The results reported here establish the utility of the yeast-based hGALE-expression system and set the stage for more-detailed studies of this important enzyme and its role in epimerase-deficiency galactosemia.

Full text

PDF
590

Images in this article

595Figure 6
on p.595

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alani E., Cao L., Kleckner N. A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains. Genetics. 1987 Aug;116(4):541–545. doi: 10.1534/genetics.112.541.test. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson M. A., Gusella J. F. Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines. In Vitro. 1984 Nov;20(11):856–858. doi: 10.1007/BF02619631. [DOI] [PubMed] [Google Scholar]
  3. Chacko C. M., McCrone L., Nadler H. L. A study of galactokinase and glucose 4-epimerase from normal and galactosemic skin fibroblasts. Biochim Biophys Acta. 1972 Oct 12;284(2):552–555. doi: 10.1016/0005-2744(72)90153-2. [DOI] [PubMed] [Google Scholar]
  4. Darrow R. A., Rodstrom R. Purification and properties of uridine diphosphate galactose 4-epimerase from yeast. Biochemistry. 1968 May;7(5):1645–1654. doi: 10.1021/bi00845a005. [DOI] [PubMed] [Google Scholar]
  5. Daude N., Gallaher T. K., Zeschnigk M., Starzinski-Powitz A., Petry K. G., Haworth I. S., Reichardt J. K. Molecular cloning, characterization, and mapping of a full-length cDNA encoding human UDP-galactose 4'-epimerase. Biochem Mol Med. 1995 Oct;56(1):1–7. doi: 10.1006/bmme.1995.1048. [DOI] [PubMed] [Google Scholar]
  6. Elsevier J. P., Wells L., Quimby B. B., Fridovich-Keil J. L. Heterodimer formation and activity in the human enzyme galactose-1-phosphate uridylyltransferase. Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7166–7171. doi: 10.1073/pnas.93.14.7166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Frey P. A. The Leloir pathway: a mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose. FASEB J. 1996 Mar;10(4):461–470. [PubMed] [Google Scholar]
  8. Fridovich-Keil J. L., Jinks-Robertson S. A yeast expression system for human galactose-1-phosphate uridylyltransferase. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):398–402. doi: 10.1073/pnas.90.2.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fridovich-Keil J. L., Langley S. D., Mazur L. A., Lennon J. C., Dembure P. P., Elsas J. L., 2nd Identification and functional analysis of three distinct mutations in the human galactose-1-phosphate uridyltransferase gene associated with galactosemia in a single family. Am J Hum Genet. 1995 Mar;56(3):640–646. [PMC free article] [PubMed] [Google Scholar]
  10. Fridovich-Keil J. L., Quimby B. B., Wells L., Mazur L. A., Elsevier J. P. Characterization of the N314D allele of human galactose-1-phosphate uridylyltransferase using a yeast expression system. Biochem Mol Med. 1995 Dec;56(2):121–130. doi: 10.1006/bmme.1995.1067. [DOI] [PubMed] [Google Scholar]
  11. Gentz R., Chen C. H., Rosen C. A. Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis. Proc Natl Acad Sci U S A. 1989 Feb;86(3):821–824. doi: 10.1073/pnas.86.3.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gitzelmann R. Deficiency of uridine diphosphate galactose 4-epimerase in blood cells of an apparently healthy infant. Preliminary communication. Helv Paediatr Acta. 1972 Jun;27(2):125–130. [PubMed] [Google Scholar]
  13. Gitzelmann R., Steinmann B. Uridine diphosphate galactose 4-epimerase deficiency. II. Clinical follow-up, biochemical studies and family investigation. Helv Paediatr Acta. 1973 Dec;28(6):497–510. [PubMed] [Google Scholar]
  14. Holton J. B., Gillett M. G., MacFaul R., Young R. Galactosaemia: a new severe variant due to uridine diphosphate galactose-4-epimerase deficiency. Arch Dis Child. 1981 Nov;56(11):885–887. doi: 10.1136/adc.56.11.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Johnston M. A model fungal gene regulatory mechanism: the GAL genes of Saccharomyces cerevisiae. Microbiol Rev. 1987 Dec;51(4):458–476. doi: 10.1128/mr.51.4.458-476.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kingsley D. M., Kozarsky K. F., Hobbie L., Krieger M. Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal/UDP-GalNAc 4-epimerase deficient mutant. Cell. 1986 Mar 14;44(5):749–759. doi: 10.1016/0092-8674(86)90841-x. [DOI] [PubMed] [Google Scholar]
  17. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  18. Langer R., Glaser L. Interaction of nucleotides with liver uridine diphosphate-glucose-4'-epimerase. J Biol Chem. 1974 Feb 25;249(4):1126–1132. [PubMed] [Google Scholar]
  19. MAXWELL E. S. The enzymic interconversion of uridine diphosphogalactose and uridine diphosphoglucose. J Biol Chem. 1957 Nov;229(1):139–151. [PubMed] [Google Scholar]
  20. Merril C. R., Das A. K., LaPolla R. J., Prissovsky I. Microassay for UDP-galactose 4-epimerase activity. Anal Biochem. 1976 May 7;72:606–613. doi: 10.1016/0003-2697(76)90573-x. [DOI] [PubMed] [Google Scholar]
  21. Mitchell B., Haigis E., Steinmann B., Gitzelmann R. Reversal of UDP-galactose 4-epimerase deficiency of human leukocytes in culture. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5026–5030. doi: 10.1073/pnas.72.12.5026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Piller F., Hanlon M. H., Hill R. L. Co-purification and characterization of UDP-glucose 4-epimerase and UDP-N-acetylglucosamine 4-epimerase from porcine submaxillary glands. J Biol Chem. 1983 Sep 10;258(17):10774–10778. [PubMed] [Google Scholar]
  23. Quimby B. B., Wells L., Wilkinson K. D., Fridovich-Keil J. L. Functional requirements of the active site position 185 in the human enzyme galactose-1-phosphate uridylyltransferase. J Biol Chem. 1996 Oct 25;271(43):26835–26842. doi: 10.1074/jbc.271.43.26835. [DOI] [PubMed] [Google Scholar]
  24. Salo W. L., Nordin J. H., Peterson D. R., Bevill R. D., Kirkwood S. The specificity of UDP-glucose 4-epimerase from the yeast Saccharomyces fragilis. Biochim Biophys Acta. 1968 Feb 5;151(2):484–492. doi: 10.1016/0005-2744(68)90116-2. [DOI] [PubMed] [Google Scholar]
  25. Sardharwalla I. B., Wraith J. E., Bridge C., Fowler B., Roberts S. A. A patient with severe type of epimerase deficiency galactosaemia. J Inherit Metab Dis. 1988;11 (Suppl 2):249–251. doi: 10.1007/BF01804249. [DOI] [PubMed] [Google Scholar]
  26. Thoden J. B., Frey P. A., Holden H. M. Crystal structures of the oxidized and reduced forms of UDP-galactose 4-epimerase isolated from Escherichia coli. Biochemistry. 1996 Feb 27;35(8):2557–2566. doi: 10.1021/bi952715y. [DOI] [PubMed] [Google Scholar]
  27. Tsai C. M., Holmberg N., Ebner K. E. Purification, stabilization, and properties of bovine mammary UDP-galactose 4-epimerase. Arch Biochem Biophys. 1970 Jan;136(1):233–244. doi: 10.1016/0003-9861(70)90347-4. [DOI] [PubMed] [Google Scholar]
  28. WILSON D. B., HOGNESS D. S. THE ENZYMES OF THE GALACTOSE OPERON IN ESCHERICHIA COLI. I. PURIFICATION AND CHARACTERIZATION OF URIDINE DIPHOSPHOGALACTOSE 4-EPIMERASE. J Biol Chem. 1964 Aug;239:2469–2481. [PubMed] [Google Scholar]
  29. Wilson I. A., Niman H. L., Houghten R. A., Cherenson A. R., Connolly M. L., Lerner R. A. The structure of an antigenic determinant in a protein. Cell. 1984 Jul;37(3):767–778. doi: 10.1016/0092-8674(84)90412-4. [DOI] [PubMed] [Google Scholar]
  30. Zeschnigk M., von Wilcken-Bergmann B., Starzinski-Powitz A. cDNA from rat cells with reconstitutive galactose-epimerase activity in E. coli. Nucleic Acids Res. 1990 Sep 11;18(17):5289–5289. doi: 10.1093/nar/18.17.5289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Zydowsky L. D., Ho S. I., Baker C. H., McIntyre K., Walsh C. T. Overexpression, purification, and characterization of yeast cyclophilins A and B. Protein Sci. 1992 Aug;1(8):961–969. doi: 10.1002/pro.5560010801. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES